GEN Exclusives

More »

GEN News Highlights

More »
Apr 30, 2008

Illumina and Genpathway Collaborate on Whole-Genome ChIP-Sequencing Services

  • Illumina and Genpathway are joining forces to provide whole-genome ChIP sequencing. The combined services will help identify and quantify transcription-factor binding sites across the entire genome.

    Samples will be prepared using Genpathway’s FactorPath ChIP assays and sequenced by Illumina’s Genome Analyzer through its sequencing services. Genpathway  will do the final data analysis. The combined services will also include cell or tissue processing, antibody selection and qualification, and quality-control steps throughout the assay.

    “One of the top applications for sequencing is ChIP, a notoriously time-consuming and difficult procedure,” points out Mary Harper, Ph.D., CSO of Genpathway. “Combining Genpathway’s expertise in ChIP and data-analysis services with Illumina’s high-throughput next-generation sequencing technology and services provides researchers a faster path to discovery.”



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Stopping Research Fraud

What is the best approach to curbing scientific misconduct and outright fraud?